All Stories

  1. Rationale and design of the EU-CERT-ICD prospective study: comparative effectiveness of prophylactic ICD implantation
  2. Sex differences in outcomes of primary prevention implantable cardioverter defibrillator therapy: combined registry data from eleven European countries
  3. P1614T wave alternans in patients with an implanted cardioverter defibrillator: results of spectral and modified moving average method differ considerably
  4. T-wave loop area from a pre-implant 12-lead ECG is associated with appropriate ICD shocks
  5. ICD risk stratification studies – EU-CERT-ICD and the European perspective
  6. ICD-Therapie: Primär- und Sekundärprävention
  7. Gender Differences in Appropriate Shocks and Mortality among Patients with Primary Prophylactic Implantable Cardioverter-Defibrillators: Systematic Review and Meta-Analysis
  8. Prediction of Appropriate Shocks Using 24-Hour Holter Variables and T-Wave Alternans After First Implantable Cardioverter-Defibrillator Implantation in Patients With Ischemic or Nonischemic Cardiomyopathy
  9. Changes in Implantation Patterns and Therapy Rates of Implantable Cardioverter Defibrillators over Time in Ischemic and Dilated Cardiomyopathy Patients
  10. 153-01: Repeated assessment of non-invasive risk stratification in the EUTrigTreat study
  11. Serial assessment of left atrial deformation in patients undergoing pulmonary vein isolation: a cardiovascular magnetic resonance feasibility study
  12. Sex difference in appropriate shocks but not mortality during long-term follow-up in patients with implantable cardioverter-defibrillators
  13. Sex-dependent alterations of Ca2+cycling in human cardiac hypertrophy and heart failure
  14. Longevity of implantable cardioverter-defibrillators in a single-center population
  15. Natriuretic peptides for the detection of paroxysmal atrial fibrillation
  16. Advances in heart rate variability signal analysis: joint position statement by the e-Cardiology ESC Working Group and the European Heart Rhythm Association co-endorsed by the Asia Pacific Heart Rhythm Society
  17. A randomized study of remote monitoring and fluid monitoring for the management of patients with implanted cardiac arrhythmia devices
  18. Submuscular implantation of insertable cardiac monitors improves the reliability of detection of atrial fibrillation
  19. Sex differences in ICD benefit
  20. Rationale and design of the MONITOR-ICD study
  21. Effects of Ranolazine on Torsades de Pointes Tachycardias in a Healthy Isolated Rabbit Heart Model
  22. Measurement of Left Atrial Pressure is a Good Predictor of Freedom From Atrial Fibrillation
  23. Single-ring ablation compared with standard circumferential pulmonary vein isolation using remote magnetic catheter navigation
  24. Remote magnetic navigation for circumferential pulmonary vein ablation: single-catheter technique or additional use of a circular mapping catheter?
  25. Evaluation of machine learning methods for the long-term prediction of cardiac diseases
  26. Antiarrhythmic Drug Therapy for Maintaining Sinus Rhythm Early after Pulmonary Vein Ablation in Patients with Symptomatic Atrial Fibrillation
  27. Vorhofflimmern
  28. Ventricular Oversensing after ICD Lead Replacement: What Is the Mechanism?
  29. Ranolazine Maintained Sinus Rhythm in a Patient with Refractory Symptomatic Atrial Fibrillation
  30. Supraventricular tachycardia with ‘A-A-V’ response upon ventricular entrainment and transient 2:1 AV conduction block
  31. Double left ventricular pacing following accidental malpositioning of the right ventricular electrode during implantation of a cardiac resynchronization therapy device
  32. Atrial standstill in a patient with progressive severe heart failure
  33. Detection of left atrial thrombus during routine diagnostic work-up prior to pulmonary vein isolation for atrial fibrillation: Role of transesophageal echocardiography and multidetector computed tomography
  34. Long-Term Prognostic Value of Restitution Slope in Patients with Ischemic and Dilated Cardiomyopathies
  35. Randomized Clinical evaluatiON of wireless fluid monitoriNg and rEmote ICD managemenT using OptiVol alert-based predefined management to reduce cardiac decompensation and health care utilization: The CONNECT-OptiVol study
  36. Renal artery ablation instead of pulmonary vein ablation in a hypertensive patient with symptomatic, drug-resistant, persistent atrial fibrillation
  37. Misleading Long Post-Pacing Interval After Entrainment of Typical Atrial Flutter From the Cavotricuspid Isthmus
  38. Rationale, objectives, and design of the EUTrigTreat clinical study: a prospective observational study for arrhythmia risk stratification and assessment of interrelationships among repolarization markers and genotype
  39. Low-energy control of electrical turbulence in the heart
  40. Remote magnetic versus manual catheter navigation for circumferential pulmonary vein ablation in patients with atrial fibrillation
  41. Kardiale Synkope
  42. Assessment of repolarization heterogeneity for prediction of mortality in cardiovascular disease: peak to the end of the T wave interval and nondipolar repolarization components
  43. Inappropriate Sensing in a Single-Chamber ICD-What is the Mechanism?
  44. T-Wave Alternans Testing in Pacemaker Patients: Comparison of Pacing Modes and Long-Term Prognostic Relevance
  45. Sternal fracture after elective electrical cardioversion of atrial fibrillation
  46. Interference of remote magnetic catheter navigation and ablation with implanted devices for pacing and defibrillation
  47. Ventricular oversensing due to manufacturer-related differences in implantable cardioverter-defibrillator signal processing and sensing lead properties
  48. Extra cardiac findings by 64-multidetector computed tomography in patients with symptomatic atrial fibrillation prior to pulmonal vein isolation
  49. Loss of capture late after right ventricular pacing lead revision: what is the mechanism?
  50. Inappropriate implantable cardioverter-defibrillator therapy during exercise: What is the mechanism?
  51. Cardiac resynchronization therapy and atrial overdrive pacing for the treatment of central sleep apnoea
  52. 64-Multidetector-row spiral CT in pulmonary embolism with emphasis on incidental findings
  53. Far-field oversensing of atrial signals: an unusual cause for very short V-V intervals and inappropriate implantable cardioverter defibrillator therapy
  54. Automatic home monitoring of implantable cardioverter defibrillators
  55. Role of Coronary Angiography Before Radiofrequency Ablation in Patients Presenting With Paroxysmal Supraventricular Tachycardia
  56. Unusual cause for an increase of the sensing integrity counter in a patient with inappropriate implantable cardioverter-defibrillator therapy
  57. Model-based inferences for clinical applications of the ECG
  58. Cardiac Arrest and Ventricular Tachycardia in Japanese-Type Apical Hypertrophic Cardiomyopathy
  59. AB13-6
  60. P3-33
  61. Arrhythmogenic right ventricular dysplasia presenting as right ventricular outflow tract tachycardia
  62. 52-j�hriger Patient mit rezidivierenden Synkopen und tempor�ren rechtspr�kordialen EKG-Ver�nderungen bei Fieber
  63. Myocardial viability evaluation using magnetocardiography in patients with coronary artery disease
  64. Tachykarde und bradykarde Rhythmusstörungen beim akuten Myokardinfarkt
  65. Antiarrhythmic therapy during cardiac arrest electrical defibrillation and antiarrhythmic drugs
  66. Antiarrhythmische Therapie beim akuten Herz-Kreislaufstillstand
  67. Predictive value of T-wave morphology variables and QT dispersion for postmyocardial infarction risk assessment
  68. Rate-dependence of QT dispersion and the QT interval: comparison of atrial pacing and exercise testing
  69. Analysis of 12-Lead T-Wave Morphology for Risk Stratification After Myocardial Infarction
  70. Predictive value of T-wave alternans for arrhythmic events in patients with congestive heart failure
  71. Electrophysiological basis of QT dispersion measurements
  72. QT-Dispersion: Role in Clinical Decision Making
  73. T-Wellen-Alternans im Mikrovoltbereich als neuer Indikator einer gestörten ventrikulären Repolarisation: Pathophysiologie, Methodik, klinische Ergebnisse
  74. Prevalence, characteristics and prognostic value during long-term follow-up of nonsustained ventricular tachycardia after myocardial infarction in the thrombolytic era
  75. Kardialer autonomer Tonus zur Risikostratifikation nach Myokardinfarkt: Ergebnisse einer prospektiven Langzeit-Studie bei 411 konsekutiven Patienten
  76. Comparison of ECG Variables of Dispersion of Ventricular Repolarization with Direct Myocardial Repolarization Measurements in the Human Heart
  77. T Wave Alternans as a Predictor of Recurrent Ventricular Tachyarrhythmias in ICD Recipients: Prospective Comparison with Conventional Risk Markers
  78. Assessment of QT Dispersion for Prediction of Mortality or Arrhythmic Events After Myocardial Infarction : Results of a Prospective, Long-term Follow-up Study
  79. Kurzzeitanalyse der Herzfrequenzvariabilität im Zeitbereich zur Prognosebeurteilung nach Myokardinfarkt: methodologisch sinnvolle Alternative zum Langzeit-EKG?
  80. Pathophysiologische Bedeutung und prognostische Wertigkeit der QT-Dispersion im Oberflächen-EKG
  81. Differential Effects of D-Sotalol, Quinidine, and Amiodarone on Dispersion of Ventricular Repolarization in the Isolated Rabbit Heart
  82. Is Dispersion of Ventricular Repolarization Rate Dependent?
  83. Electrophysiologic Features of Torsades de Pointes:.
  84. Heart Rate Variability Used as an Arrhythmia Risk Stratifier After Myocardial Infarction
  85. T Wave Alternans During Exercise and Atrial Pacing in Humans
  86. Dispersion of Ventricular Repolarization — Myocardial and Electrocardiographic Markers
  87. Myocardial Vulnerability to T Wave Shocks: Relation to Shock Strength, Shock Coupling Interval, and Dispersion of Ventricular Repolarization
  88. Mechanism of ventricular fibrillation induction by T wave shocks in patients
  89. Lack of stability of late potentials during the first year after myocardial infarction in the thrombolytic era
  90. Effect of Sustained Load on Dispersion of Ventricular Repolarization and Conduction Time in the Isolated Intact Rabbit Heart
  91. Autonomic Modulation in Postinfarction Patients with Sustained Ventricular Tachyarrhythmias
  92. Computer Analysis of Monophasic Action Potentials: Manual Validation and Clinically Pertinent Applications
  93. Electrocardiographic indexes of dispersion of ventricular repolarization: An isolated heart validation study
  94. 947-115 Comparative Effects of D-Sotalol, Quinidine and Amiodarone on Dispersion of Ventricular Repolarization in the Isolated Intact Rabbit Heart
  95. 1055-1 A Program for Digitization of ECG Tracings on Paper and Accurate Interactive Measurement of QT Intervals and ECG Parameters of Dispersion of Ventricular Repolarization
  96. Open infarct artery, late potentials, and other prognostic factors in patients after acute myocardial infarction in the thrombolytic era. A prospective trial
  97. Changes in Autonomic Tone Following Thrombolytic Therapy for Acute Myocardial Infarction:.
  98. Bedeutung des autonomen Nervensystems bei paroxysmalem Vorhofflimmern
  99. Bedside markers of coronary reperfusion
  100. Effect of sotalol on heart rate variability assessed by Holter monitoring in patients with ventricular arrhythmias
  101. Relation of diurnal variation of ventricular repolarization to ventricular ectopic activity and modification by sotalol
  102. Usefulness of ckmb and troponin t determinations in patients with acute myocardial infarction complicated by ventricular fibrillation
  103. Efficacy and safety of sotalol in patients with complex ventricular arrhythmias
  104. Efficacy of Intravenously Administered Amiodarone for Short-Term Control of Serious Arrhythmias
  105. ST segment analysis for assessment of coronary artery patency: comparison of surface ECG and Holter recordings
  106. Intraindividual Reproducibility of Heart Rate Variability
  107. Short- and long-term efficacy and safety of flecainide acetate for supraventricular arrhythmias
  108. Arrhythmias during the acute phase of reperfusion therapy for acute myocardial infarction: Effects of β-adrenergic blockade
  109. Short- and long-term antiarrhythmic and hemodynamic effects of d,l-sotalol in patients with symptomatic ventricular arrhythmias
  110. Efficacy of Intravenously Administered Amiodarone for Short-Term Control of Serious Arrhythmias
  111. Assessment of coronary artery patency after thrombolytic therapy: Accurate prediction utilizing the combined analysis of three noninvasive markers
  112. Combined analysis of three noninvasive harkers for better prediction of reperfusion after thrombolytic therapy for acute myocardial infarction
  113. Neue Aspekte zur Therapie mit Klasse-III-Antiarrhythmika
  114. Comparison of twice daily with thrice daily administered encainide for benign or potentially lethal ventricular arrhythmias
  115. Morphological Assessment of T Wave Patterns